PMID- 32773572 OWN - NLM STAT- MEDLINE DCOM- 20210219 LR - 20210219 IS - 1752-2978 (Electronic) IS - 1752-296X (Linking) VI - 27 IP - 5 DP - 2020 Oct TI - The potential of a ketogenic diet to minimize effects of the metabolic fault in glycogen storage disease V and VII. PG - 283-290 LID - 10.1097/MED.0000000000000567 [doi] AB - PURPOSE OF REVIEW: To explore the potential of a low carbohydrate ketogenic diet (LCKD) to counter physical activity intolerance, pain and muscle damage for glycogen storage disease (GSD) V and VII, and highlight the realistic possibility that nutrition could be key. RECENT FINDINGS: Carbohydrate (CHO) ingestion during physical activity in GSDV and a LCKD for GSDVII is common. For the latter, a long-term study demonstrated improvement in physiological markers while on a LCKD. This included improvement in aerobic power and activity tolerance. In GSDV, preliminary research on a LCKD suggest a diet of 75% fat, 15% protein, 10% CHO, is best for improved function and compliance. Ketones provide immediate fuel for acute physical activity, and have an epigenetic role, improving ketone and lipid use. Evidence from elite athletes found a LCKD can increase fat oxidation and is optimal at 70% VO2max. This suggests the need to also improve conditioning via exercise to maximize the benefit of a LCKD. SUMMARY: A high CHO diet in GSDV and VII comes with a restricted physical activity capacity alongside significant pain, muscle damage and risk of renal failure. Mounting evidence suggests a LCKD is efficacious for both disorders providing an immediate fuel source which may negate the need for a 'warm-up' prior to every activity and restore 'normal' function. FAU - Reason, Stacey L AU - Reason SL AD - International Association for Muscle Glycogen Storage Disease, San Francisco, California, USA. FAU - Godfrey, Richard J AU - Godfrey RJ AD - Centre for Human Performance, Exercise and Rehabilitation, Brunel University, London, UK. LA - eng PT - Journal Article PT - Review PL - England TA - Curr Opin Endocrinol Diabetes Obes JT - Current opinion in endocrinology, diabetes, and obesity JID - 101308636 SB - IM MH - Diet, Carbohydrate-Restricted MH - *Diet, Ketogenic MH - Exercise Tolerance/physiology MH - Glycogen Storage Disease Type V/complications/*diet therapy/metabolism MH - Glycogen Storage Disease Type VII/complications/*diet therapy/metabolism MH - Humans MH - Lung Volume Measurements MH - Muscle, Skeletal/metabolism MH - Oxidation-Reduction EDAT- 2020/08/11 06:00 MHDA- 2021/02/20 06:00 CRDT- 2020/08/11 06:00 PHST- 2020/08/11 06:00 [pubmed] PHST- 2021/02/20 06:00 [medline] PHST- 2020/08/11 06:00 [entrez] AID - 01266029-202010000-00007 [pii] AID - 10.1097/MED.0000000000000567 [doi] PST - ppublish SO - Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):283-290. doi: 10.1097/MED.0000000000000567.